EL
ESTEE LAUDER COMPANIES INC (EL)·Q4 2025 Earnings Summary
Executive Summary
- Q4 FY2025 reported net sales were $3.41B (-12% YoY) and adjusted diluted EPS was $0.09; GAAP diluted EPS was -$1.51 due to $527M of restructuring and intangible impairment charges and a $172M U.S. deferred tax valuation allowance .
- Results were broadly in line with consensus; revenue modestly beat ($3.41B vs $3.40B*) and EPS matched/slightly beat ($0.09 vs $0.089*), with EBITDA essentially in line ($319M vs $318.8M*) ; estimates from S&P Global*.
- Sequential deterioration vs Q3 reflected a stronger double-digit decline in global travel retail and softness in mainland China amid subdued consumer sentiment, partly offset by luxury fragrance growth (Le Labo, Jo Malone London) .
- FY2026 outlook introduced: organic net sales 0–3%, GAAP net sales +2–5%, adjusted EPS $1.90–$2.10, adjusted operating margin 9.4–9.9%, ~36% adjusted ETR, CFO $1.0–$1.1B, capex ~4% of sales; tariff headwind ≈$100M .
- Catalysts: affirmation of FY26 turnaround (return to growth, margin build), PRGP execution (cost saves funding consumer investments), and channel expansion (Amazon, specialty multi) .
What Went Well and What Went Wrong
-
What Went Well
- Luxury fragrance momentum: Le Labo delivered strong double-digit growth each quarter; Jo Malone London strength continued; Q4 fragrance net sales +2% organically .
- Gross margin resilience: adjusted gross margin held ~72% in Q4 despite volume deleverage; FY gross margin expanded 230 bps to 74% on PRGP efficiencies and reduced obsolescence/discounts .
- Share gains and consumer coverage: share gains in China (all categories), Japan, and improved U.S. share trends; expanded Amazon premium beauty storefronts (11 U.S. brands; new Canada, Mexico) .
- Management quote: “We embarked on fiscal 2026 with signs of momentum and confidence in our outlook to deliver organic sales growth this year… and to begin rebuilding operating profitability” — CEO Stéphane de La Faverie .
-
What Went Wrong
- Travel retail and Asia softness: sequential deterioration driven by stronger double-digit decline in travel retail and subdued China sentiment; retailer inventory tightening pressured shipments .
- Impairments and restructuring: Q4 included $425M intangible impairments (Dr.Jart+, Too Faced) and $106M restructuring, dragging GAAP profitability; FY impairments totaled $1.286B .
- Makeup and hair care declines: Q4 makeup -12% organically (M·A·C, Too Faced; face category weakness), hair care -15% (Aveda’s brick-and-mortar softness) .
Financial Results
Actual vs S&P Global consensus (Q4 FY2025):
Values marked with * are from S&P Global.
Segment net sales (Q4 FY2025 vs prior year):
Geographic net sales (legacy structure):
Drivers:
- Organic net sales -13% in Q4, led by Skin Care (-17%) and Makeup (-12%); Fragrance +2% on luxury brands .
- Operating loss -$390M GAAP; adjusted operating loss -$288M; impairment/restructuring weighed on GAAP .
Guidance Changes
Additional qualitative guidance: Expect high-single-digit growth in global travel retail in Q1 FY2026, mid-single-digit growth in mainland China; tighter trade inventories and reduced discounts to align retail and net sales .
Earnings Call Themes & Trends
Management Commentary
- “We enter fiscal ’26 with signs of momentum and the start of our turnaround, a return to top line growth in fiscal ’26 and the pursuit of a solid double digit operating margin in the years ahead.” — CEO Stéphane de La Faverie .
- “Gross margin for the full year… 74%. This meaningful expansion was driven by the relentless execution of our PRGP.” — CFO Akhil Shrivastava .
- “We now have a much more diversified business… department stores are… less than one third of our business.” — CFO Akhil Shrivastava on North America mix .
- “Our investments in AI have begun to show meaningful impact… AI has driven a 31% increase in ROI from our North America media campaigns.” — CEO Stéphane de La Faverie .
Q&A Highlights
- Retail vs net sales gap: Inventory reductions across major markets; expect net to track retail more closely, though Q1 North America gap remains elevated before narrowing through FY2026 .
- North America strategy: Emphasis on Amazon and specialty multi; continued de-emphasis of department stores while ensuring profitable channel mix .
- Margin build: FY2026 operating margin expansion driven primarily by SG&A reductions (non-consumer-facing) with gross margin flat-to-up despite tariffs; longer-term opportunities in procurement and outsourcing .
- Europe outlook: Consumer softness in Western Europe (France, Germany) offset by targeted investments, innovation acceleration, and luxury fragrance expansion .
- Confidence in FY2026: Visibility improving in China and travel retail shipments; PRGP savings underpin margin and cash targets, with prudence around exogenous risks .
Estimates Context
- Q4 FY2025 actuals compared with S&P Global consensus: revenue $3.411B vs $3.399B* (beat), EPS $0.09 vs $0.089* (in line/slight beat), EBITDA $319M vs $318.8M* (in line). Values marked with * are from S&P Global.
- Implication: Modest operational beats amid significant GAAP noise from impairments/restructuring; estimate revisions likely to focus on FY2026 margin cadence (SG&A leverage) and travel retail recovery path .
Key Takeaways for Investors
- FY2026 setup: Targeted return to organic growth (0–3%) and 160–190 bps operating margin expansion, with cost saves funding consumer acquisition; watch SG&A execution and tariff offsets .
- Channel strategy: Rapid expansion in Amazon and specialty multi is reshaping North America, reducing reliance on department stores and improving ROI via AI-enabled media .
- China trajectory: Signs of stabilization and share gains in H2 FY2025; FY2026 assumes mid-single-digit growth — monitor shopping festivals and online momentum .
- Travel retail normalization: Shipments expected to improve vs FY2025; conversion remains weak — sequential variability likely, with broader recovery into 2H FY2026 .
- Gross margin resilience: PRGP continues to offset deleverage; focus shifts to SG&A and procurement/outsourcing for additional leverage .
- Brand performance: Luxury fragrance (Le Labo, Jo Malone London) a bright spot; Skin Care and Makeup require continued innovation and pricing/discount discipline .
- Cash and dividends: FY2026 CFO $1.0–$1.1B despite peak restructuring payments; dividend maintained at $0.35, supporting income investors while funding turnaround .